Agomab Unveils Plans for Initial Public Offering
Agomab has appointed JP Morgan, Morgan Stanley, Leerink Partners and Van Lanschot Kempen as joint book-running managers for the proposed Initial Public Offering (IPO), marking a key step in its plans to access the public markets.
Agomab | 03/02/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy